AGAjay K. Gade

Ajay K. Gade

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ajay K. Gade has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical Outcomes in Acute Decompensated Metabolic Dysfunction-associated Steatotic Liver Disease Cirrhosis: The Role of BMI in Mortality, Readmission, and Hospital Stay

    by Ajay Gade, Bhavani N. Papudesi, Sam Joseph

    Background This study examines the impact of Body Mass Index (BMI) on mortality, readmission rates, and hospital stay lengths in patients with acute decompensated non-alcoholic fatty liver cirrhosis, now termed metabolic dysfunction-associated steatotic liver disease (MASLD). Objective To assess the relationship between BMI and outcomes such as mortality, readmission rates, and hospital and ICU lengths of stay in patients with acute decompensated MASLD. Design Retrospective cohort analysis. Participants Conducted at Grand Strand Medical Center, Myrtle Beach, SC, this study included 43,942 patients, using data from the Hospital Corporation of America Enterprise Data Warehouse from 2017–2022. Main Measures Logistic regression and negative binomial models were used, adjusting for age, gender, race, diabetes, and hyperlipidemia. Key Results A notable “obesity paradox” was observed: underweight patients had over twice the odds of mortality (OR = 2.12, 95% CI: 1.83–2.46; p < 0.0001) compared to healthy-weight patients, suggesting a protective effect of higher BMI. While BMI did not significantly affect overall readmission, patients with Class III obesity had lower readmission odds (OR = 0.86, 95% CI: 0.77–0.96; p = 0.0012). However, Class III obesity was linked to increased hospital (IRR = 1.20, 95% CI: 1.15–1.26; p < 0.0001) and ICU LOS (IRR = 1.12, 95% CI: 1.04–1.20; p < 0.0001). Diabetes (IRR = 1.09, 95% CI: 1.06–1.11) and hyperlipidemia (IRR = 1.34, 95% CI: 1.31–1.38) were also associated with longer LOS (p < 0.0001). Conclusion These findings highlight the complexity of BMI’s role in MASLD outcomes. The observed obesity paradox warrants further investigation to inform care strategies across BMI categories.


  • Open Access

    Medical Management of Crohn's Disease

    by Ajay K. Gade, Nathan T. Douthit, Erin Townsley

    Crohn's disease (CD) is a chronic inflammatory bowel disease that can affect the entire gastrointestinal tract from the mouth to the anus, sparing the rectum. The goal of medical therapy is to induce remission with medications, followed by the administration of maintenance medications to prevent a relapse of the disease. The concept of induction of remission and maintenance of remission is very important, as there is an overlap of medications used to induce and maintain remission. Physicians first direct treatment to induce a remission that involves relief of symptoms and mucosal healing of the lining of the colon and then provide long-term treatment to maintain the remission. Standard treatment for CD depends on the extent of involvement and disease severity, for example, mild, moderate, severe, and fulminant.


  • Open Access

    Carcinoid Syndrome: A Review

    by Ajay K. Gade, Eva Olariu, Nathan T. Douthit

    Carcinoid syndrome (CS) is a paraneoplastic syndrome caused by the release of serotonin and other substances from well-differentiated neuroendocrine tumors (NETs). The hallmark symptoms of carcinoid syndrome are flushing and diarrhea; atypical signs and symptoms can include wheezing, abdominal pain, valvular heart disease, telangiectasias, pellagra, and the complications of mesenteric fibrosis, including ureteral obstruction, bowel obstruction, and bowel ischemia. These symptoms are mediated by the release of serotonin (5-HT), histamine, kallikrein, prostaglandins, and tachykinins. The diagnosis of CS requires these symptoms and corresponding elevations in lab tests. Treatment options include surgery and medical management with somatostatin analogs.


  • Open Access

    A Rare Case of Plummer-Vinson Syndrome

    by Ajay K. Gade, Lauren Pacheco

    Plummer-Vinson syndrome (PVS) is characterized by a triad of symptoms comprising microcytic hypochromic anemia, esophageal webs, and dysphagia. PVS is commonly found in women of middle age especially in the fourth and fifth decade of life and is rarely reported in males. We report a case of a 39-year-old female patient who had a classic presentation of PVS. PVS is precancerous with high malignant potential; early diagnosis is of utmost importance for better prognosis and surveillance endoscopy is recommended. Iron repletion oftentimes improves the dysphagia; seldom esophageal dilatation is used to provide symptomatic relief.